脑部放疗，上午比下午敏感许多！
; D$ l! z3 J9 r6 I" V- u6 k: d* m* P: P) x0 Q1 T
9 x; A6 w/ I& @9 e, eCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
9 r, |. A9 W8 m6 JGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?; |) q0 N: A) M) e
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
8 c7 b% M$ J5 U1 K1 \4 O' ASourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.5 l0 J+ W g' Q8 z& f! l
1 X6 v; U( {$ ?, s+ B2 `! @
Abstract s) `' C& n! {6 K; T, h
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
) |( t( v1 F) q! \2 t' L
- D9 S/ ]2 }8 i$ ~0 e, H3 S& |METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
) Z4 J8 r( }- s- m C0 y! ` @. c- E* N, O0 f0 h# N6 y% A. D6 }: V
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
7 i$ N3 y, u, w5 n" p5 T2 z0 v2 B% S6 Z
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
1 C, a* }) z. T- b9 n; C+ O4 ~# e% ]% B$ t9 K/ A! V- V0 W
|
麻烦推荐上海肿瘤医院做肾脏手术的医
父亲这两天做ct发现有肿物，医院初步判断不太好，可能需要做手术，求各位推荐上海肿瘤
肺癌免疫耐药仍有治愈希望，70%肺癌
作者：seacat
2025年6月5日，信达生物宣布其全球首创PD-1/IL-2α偏向性双特异性融合蛋
L861Q多发脑转和脑膜转使用佐利替尼
患者是我妈妈，今年71岁，治疗经过如下：
2023-6-7 确诊右肺上叶肺腺癌伴多发淋巴结、
沿敌油的真实效果反馈
沿敌油留言抽奖活动从23年3月份到现在已经做过22次活动了，与爱也收集了大家使用过的
小细胞肺癌4年9个月倍瑞博营养分享
我家2020.9确诊小细胞肺癌，当时头，肝，肾上腺，综合淋巴都转移，我们马上就进行了放
7 V$ H6 v5 Y# U* _* a# m
显身卡
